Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to Heart Rhythm
- Polygenic risk scores in coronary artery disease and atrial fibrillation.Heart Lung Circ. 2020; 29: 634-640
- Genome-wide association studies for complex traits: consensus, uncertainty and challenges.Nat Rev Genet. 2008; 9: 356-369
- Benefits and limitations of genome-wide association studies.Nat Rev Genet. 2019; 20: 467-484
- Meta-analysis identifies six new susceptibility loci for atrial fibrillation.Nat Genet. 2012; 44: 670-675
- Predictive accuracy of a polygenic risk score for postoperative atrial fibrillation after cardiac surgery.Circ Genom Precis Med. 2021; 14e003269
- Prognostic value of a polygenic risk score for coronary heart disease in individuals aged 70 years and older.Circ Genom Precis Med. 2022; 15e003429
- Genetic predisposition, clinical risk factor burden, and lifetime risk of atrial fibrillation.Circulation. 2018; 137: 1027-1038
- Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation.Nat Genet. 2017; 49: 946-952
- Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations.Nat Genet. 2018; 50: 1219-1224
- Genetic risk prediction of atrial fibrillation.Circulation. 2017; 135: 1311-1320
- Effect of aspirin on all-cause mortality in the healthy elderly.N Engl J Med. 2018; 379: 1519-1528
- Medically actionable pathogenic variants in a population of 13,131 healthy elderly individuals.Genet Med. 2020; 22: 1883-1886
- Dynamic atrial substrate during high-density mapping of paroxysmal and persistent AF: implications for substrate ablation.JACC Clin Electrophysiol. 2019; 5: 1265-1277
- Sex-related differences in atrial remodeling in patients with atrial fibrillation: relationship to ablation outcomes.Circ Arrhythm Electrophysiol. 2022; 15e009925
- Genetic susceptibility for atrial fibrillation in patients undergoing atrial fibrillation ablation.Circ Arrhythm Electrophysiol. 2020; 13e007676
- Conduction heterogeneity: impact of underlying heart disease and atrial fibrillation.JACC Clin Electrophysiol. 2020; 6: 1844-1854
- Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria.J Am Coll Cardiol. 2001; 38: 883-891
- Genetic susceptibility to atrial fibrillation is associated with atrial electrical remodeling and adverse post-ablation outcome.JACC Clin Electrophysiol. 2020; 6: 1509-1521
- Bi-atrial characterization of the electrical substrate in patients with atrial fibrillation.Pacing Clin Electrophysiol. 2022; 45: 752-760
- Common genetic polymorphism at 4q25 locus predicts atrial fibrillation recurrence after successful cardioversion.Heart Rhythm. 2013; 10: 849-855
- A higher polygenic risk score is associated with a higher recurrence rate of atrial fibrillation in direct current cardioversion-treated patients.Medicina (Kaunas). 2021; 57: 1263
- A genetic risk score for atrial fibrillation predicts the response to catheter ablation.Korean Circ J. 2019; 49: 338-349
Publication stageIn Press Journal Pre-Proof
Funding Sources: The authors acknowledge funding support from the National Health and Medical Research Council (NHMRC) of Australia: Practitioner Fellowship (Dr Kalman), Research Scholarships (Drs Al-Kaisey, Wong, Anderson, Chieng, and Sugumar); Heart Foundation: Future Leader Fellowship (Dr Lacaze), Predictive Modelling Grant (Drs Fatkin, Kalman, Kistler, and Johnson); NSW Health: (Drs Fatkin and Johnson). The ASPirin in Reducing Events in the Elderly (ASPREE) study was supported by a Flagship cluster grant (including the Commonwealth Scientific and Industrial Research Organisation, Monash University, Menzies Research Institute, Australian National University, and University of Melbourne), by grants (U01AG029824 and U19AG062682) from the National Institute on Aging and the National Cancer Institute at the National Institutes of Health, by grants (334047 and 1127060) from the NHMRC, and by Monash University and the Victorian Cancer Agency.
Disclosures: The authors have no conflicts of interest to disclose.